Table 3.
Vesicular nanocarrier | Advantages | Disadvantages | References |
---|---|---|---|
Liposomes | Improved drug stability | Drug leakage | [22], [28], [29], [30] |
Available in various size range | Scale-up difficulty | ||
Reduced drug toxicity | Dose dumping | ||
Prolonged drug release | Sterilization problems | ||
Ethosomes | High skin permeation compared to liposomes | Chances of coalescence | [41], [42] |
Non-toxic raw materials | Poor yield problems | ||
Smaller size compared to liposomes | Less stability | ||
Transfersomes | Higher penetration compared to liposomes and ethosomes | Expensive | [53], [54] |
Systemic and topical delivery | Difficult manufacturing | ||
Transethosomes | Higher penetration compared to ethosomes | Scale-up problems | [58] |
Higher stability compared to ethosomes | Expensive |